Literature DB >> 9266229

The use of a simple home flow test as a quality indicator for male patients treated for lower urinary tract symptoms suggestive of bladder outlet obstruction.

M V Hansen1, A Zdanowski.   

Abstract

OBJECTIVE: To evaluate the performance of a simple home flow test (HFT) in the examination and follow-up of patients suffering from lower urinary tract symptoms suggestive of bladder outlet obstruction.
METHODS: One hundred seventy-two patients who were treated with either transurethral resection of the prostate or transurethral microwave therapy were included. Symptom evaluation, HFT and uroflowmetry were done before and 3 months following treatment. The patients' opinions about the need for further therapy and the effect of therapy were categorised at the follow-up.
RESULTS: The HFT correlated strongly with the maximum flow rate (Qmax) both before and after therapy and it was better correlated to the symptoms of the patients and to the subjective effect of therapy compared to the Qmax.
CONCLUSION: HFT is a cost-saving diagnostic technique for the classification of urinary flow and should be useful as a quality indicator in large-scale health care management programs.

Entities:  

Mesh:

Year:  1997        PMID: 9266229

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  3 in total

1.  Male Voiding Behavior: Insight from 19,824 At-Home Uroflow Profiles.

Authors:  Stephen J Summers; Joseph M Armstrong; Steven A Kaplan; Alex E Te; Alvin Le; Scott M Heiner; Angela P Presson; Guo Wei; James M Hotaling
Journal:  J Urol       Date:  2020-12-01       Impact factor: 7.450

Review 2.  Noninvasive Medical Tools for Evaluating Voiding Pattern in Real Life.

Authors:  Kwonsoo Chun; Su Jin Kim; Sung Tae Cho
Journal:  Int Neurourol J       Date:  2017-04-21       Impact factor: 2.835

3.  Development of an Automatic Interpretation Algorithm for Uroflowmetry Results: Application of Artificial Intelligence.

Authors:  Min Soo Choo; Ho Young Ryu; Sangchul Lee
Journal:  Int Neurourol J       Date:  2022-03-31       Impact factor: 2.835

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.